LEVP - Lev Pharmaceuticals, Inc. (OTCBB)

[Klipper22]

Keeping an eye on this because of the pennant, moving averages, and ADX. Getting some mixed signals from other indicators, but expecting a bigger move soon.

Lev Pharmaceuticals, Inc.
675 Third Avenue
Suite 2200
New York, NY 10017
United States
Phone: 212-682-3096
Fax: 212-682-2559
Web Site: http://www.levpharma.com

DETAILS
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 17

BUSINESS SUMMARY Lev Pharmaceuticals, Inc., a development stage biopharmaceutical company, develops and commercializes therapeutic products for the treatment of inflammatory diseases primarily in the United States. It develops C1-esterase inhibitor (C1-INH), a Phase III clinical trial product for the acute and prophylactic treatment of hereditary angioedema, which is a genetic disorder characterized by episodic attacks of edema in the extremities, face, abdomen, and airway passages. Lev Pharmaceuticals' product is also used for the treatment of acute myocardial infarction or heart attack, and other diseases and disorders. Lev Pharmaceuticals is based in New York, New York.

Shares Outstanding: 114.42M
Float: 32.46M

http://stockcharts.com/h-sc/ui?s=LEV...0267&listNum=1